PEPTYX BIO works exclusively with licensed healthcare professionals and qualified clinics in Thailand.
We provide quality-assured peptide products alongside the scientific education, batch documentation and clinical resources required to evaluate and implement peptide-based interventions responsibly.
Our role extends beyond supply. We help clinics build the scientific understanding, operational processes and quality oversight necessary to work with peptides with greater confidence.
FOR QUALIFIED HEALTHCARE PROFESSIONALS · PRESCRIPTION-ONLY ACCESS
Introducing peptide-based interventions requires more than access to products. It requires an understanding of the underlying biology, careful patient selection, appropriate monitoring and complete confidence in the quality and traceability of every batch.
PEPTYX BIO supports clinics across each of these areas through a structured professional partnership.
Access is limited to appropriately licensed clinics and healthcare professionals. Every application is reviewed to confirm professional credentials, scope of practice and compliance with the applicable requirements in Thailand.
Approved clinics receive structured onboarding for physicians, nurses and relevant clinic personnel. This establishes a consistent understanding of product documentation, clinical responsibilities, storage requirements and safety-reporting procedures.
Our training explains the biological pathways, mechanisms of action and current evidence associated with each peptide. We distinguish clearly between established clinical applications, emerging human evidence and predominantly preclinical research.
Clinicians receive concise evidence summaries and more detailed medical monographs covering mechanisms, areas studied, evidence maturity, safety considerations, contraindications, potential interactions and key scientific references.
Product-specific resources support appropriate receipt, storage, preparation, handling and stock management. These materials are designed to help clinics protect product integrity and maintain consistent internal processes.
We provide evidence-informed educational resources addressing factors clinicians may consider when evaluating patient suitability, establishing baseline measures and monitoring clinical response. These resources support, but do not replace, the independent judgment of the prescribing physician.
Every partner clinic has access to a defined pathway for reporting suspected adverse events, quality concerns and product complaints. Reports are documented, assessed and escalated through the appropriate medical and quality-governance processes.
Clinics can access batch-specific documentation, including applicable Certificates of Analysis, product specifications, testing information, manufacturing and expiry details, and storage requirements.
Approved clinics receive a dedicated point of contact for product documentation, scientific questions, training coordination and operational support.
Peptide science continues to evolve. Partner clinics receive ongoing evidence updates, educational briefings, training sessions and relevant regulatory or safety communications.
Every product supplied by PEPTYX BIO follows a documented quality pathway designed to support consistency, transparency and batch-level traceability.
Potential manufacturing partners are assessed against defined quality, documentation and reliability requirements before products are considered for supply.
Applicable manufacturing records, product specifications and facility documentation are reviewed as part of the qualification and release process.
Each supplied batch is independently tested against defined specifications relevant to the product. Testing may include identity, purity, potency, sterility, bacterial endotoxins and other quality parameters, as applicable.
Batch documentation and testing results are reviewed before the product is approved for release to partner clinics.
Product and batch information is maintained through delivery, enabling clinics to connect the products they receive with the corresponding quality documentation.
Submit your clinic information and the professional credentials of the responsible healthcare practitioners.
Our team reviews the clinic's credentials, professional scope and relevant compliance documentation.
Approved physicians and clinic staff complete scientific, product-handling and safety onboarding.
The clinic receives access to available products, batch documentation, medical monographs and professional resources.
Our scientific and clinical-support teams provide ongoing education, documentation assistance and relevant evidence or safety updates.
Approved clinics receive secure access to the PEPTYX BIO Professional Portal, where authorised users can access everything needed to work with peptide-based interventions responsibly: from product availability to batch-level documentation and continuing education.
PEPTYX BIO was co-founded by Dr. Elena Seranova, PhD, a cell biologist and neuroscientist with experience building and commercialising science-led longevity products internationally, including founding NMN Bio, a longevity brand sold across global markets.
Our scientific materials are developed through a defined evidence-review process and are reviewed with appropriate clinical input. We communicate both the potential and the limitations of peptide-based interventions, because biological interventions deserve biological understanding.
"Your clinic's reputation rests on the quality of what you use. Ours rests on the science behind it."
CLINIC ACCESS IS SUBJECT TO CREDENTIAL VERIFICATION AND THE APPLICABLE REGULATORY REQUIREMENTS IN THAILAND
